Vaccine immunotherapy in lung cancer: Clinical experience and future directions

γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.

Immunotherapy prospects in the treatment of lung cancer and mesothelioma

Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer